New data on the Pfizer-BioNTech coronavirus vaccine, gathered by Israel’s Ministry of Health, revealed promising signs in preventing the transmission of COVID-19 without symptoms.
The latest analysis, published on Thursday, found that after two weeks from receiving the second dose of the vaccine, it is 97% effective in preventing symptomatic COVID-19 cases and is 94% effective against infection without symptoms.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
